Document Detail

The effects of labetalol and oxprenolol on blood lipids.
MedLine Citation:
PMID:  7025257     Owner:  NLM     Status:  MEDLINE    
Since a high risk of coronary heart disease is associated with high serum total cholesterol levels and low high-density lipoprotein (HDL) cholesterol levels, the effects of labetalol (Trandate; Allen & Hanburys) and oxprenolol (Trasicor; Ciba-Geigy) on blood lipids were studied. Eight normal volunteers, mean age 25,8 years, were involved in a randomized cross-over trial; all received each of the drugs for a 3-week period, separated by a wash-out period of 1 week. Both labetalol and oxprenolol reduced total serum cholesterol levels; these changes are statistically highly significant; Since the drugs had no significant effect on HDL cholesterol levels, the ratio of total cholesterol to HDL cholesterol was significantly decreased. Changes in triglyceride levels after both labetalol and oxprenolol administration were slight and did not reach statistical significance. The alpha-blockade caused by labetalol does no materially affect changes in blood lipid values brought about by beta-blockade. This study does not support previous reports, which have directed attention towards the possibility that, owing to alterations in lipid transport, adrenergic blocking agents might accelerate atherogenesis.
D K Sommers; L S de Villiers; M van Wyk; H S Schoeman
Related Documents :
19943937 - Hypercholesterolemia and myocardial function evaluated via tissue doppler imaging.
11487447 - New developments in the prevention of atherosclerosis in patients with low high-density...
7339867 - Lipoproteins and cholesterol esterification rate in men and women with hypercholesterol...
19865527 - Sage tea drinking improves lipid profile and antioxidant defences in humans.
16276077 - Effect of olive oil-fried sardine consumption on cholesterol content in the serum, lipo...
8234127 - Effect of atherogenic diet on chicken plasma lipids and lipoproteins.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde     Volume:  60     ISSN:  0256-9574     ISO Abbreviation:  S. Afr. Med. J.     Publication Date:  1981 Sep 
Date Detail:
Created Date:  1981-11-18     Completed Date:  1981-11-18     Revised Date:  2014-09-12    
Medline Journal Info:
Nlm Unique ID:  0404520     Medline TA:  S Afr Med J     Country:  SOUTH AFRICA    
Other Details:
Languages:  eng     Pagination:  379-80     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholesterol / blood*
Cholesterol, HDL
Clinical Trials as Topic
Ethanolamines / pharmacology*
Labetalol / pharmacology*
Lipoproteins, HDL / blood
Oxprenolol / pharmacology*
Random Allocation
Triglycerides / blood*
Reg. No./Substance:
0/Cholesterol, HDL; 0/Ethanolamines; 0/Lipoproteins, HDL; 0/Triglycerides; 519MXN9YZR/Oxprenolol; 97C5T2UQ7J/Cholesterol; R5H8897N95/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Spinal cord injury. Review of basic and applied research.
Next Document:  Antihypertensive and metabolic effects of a combination of hydrochlorothiazide and amiloride.